Barclays’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Barclays’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-51,100	Closed	-$4.94M	–	5802
2020 Q2	$4.94M	Sell	51,100 -39,900	-44%	-$3.33M	﹤0.01%	1389
2020 Q1	$4.27M	Sell	91,000 -4,600	-5%	-$295K	﹤0.01%	1604
2019 Q4	$6.97M	Buy	+95,600	New	+$5.8M	﹤0.01%	1696
2018 Q3	–	Sell	-27,000	Closed	-$1.34M	–	7564
2018 Q2	$1.34M	Hold	27,000	–	–	﹤0.01%	2956
2018 Q1	$1.32M	Buy	+27,000	New	+$1.4M	﹤0.01%	2894

Barclays's MYOK Position: Q4 2020 in Review

Barclays sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 38,299 shares — an estimated $5.22M sold.

Barclays first reported a position in MYOK in Q4 2015 and held it in 20 quarters. The position peaked at $7.65M in Q4 2019. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Barclays reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Barclays sold 38,299 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $5.22M.
Barclays first reported a position in MyoKardia, Inc. Common Stock in Q4 2015 and held it in 20 quarters.
Barclays's MyoKardia, Inc. Common Stock position peaked at $7.65M in Q4 2019.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Barclays's 13F filing for Q4 2020, filed 11 Feb 2021.